Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry.
Schrezenmeier H, Röth A, Araten DJ, Kanakura Y, Larratt L, Shammo JM, Wilson A, Shayan G, Maciejewski JP. Schrezenmeier H, et al. Among authors: shammo jm. Ann Hematol. 2020 Jul;99(7):1505-1514. doi: 10.1007/s00277-020-04052-z. Epub 2020 May 10. Ann Hematol. 2020. PMID: 32390114 Free PMC article.
Paroxysmal nocturnal hemoglobinuria: patient journey and burden of disease.
Bektas M, Copley-Merriman C, Khan S, Sarda SP, Shammo JM. Bektas M, et al. Among authors: shammo jm. J Manag Care Spec Pharm. 2020 Dec;26(12-b Suppl):S8-S14. doi: 10.18553/jmcp.2020.26.12-b.s8. J Manag Care Spec Pharm. 2020. PMID: 33356781 Free PMC article. Review.
Paroxysmal nocturnal hemoglobinuria: current treatments and unmet needs.
Bektas M, Copley-Merriman C, Khan S, Sarda SP, Shammo JM. Bektas M, et al. Among authors: shammo jm. J Manag Care Spec Pharm. 2020 Dec;26(12-b Suppl):S14-S20. doi: 10.18553/jmcp.2020.26.12-b.s14. J Manag Care Spec Pharm. 2020. PMID: 33356783 Free PMC article. Review.
Clinical characteristics and outcomes according to age in lenalidomide-treated patients with RBC transfusion-dependent lower-risk MDS and del(5q).
Fenaux P, Giagounidis A, Selleslag D, Beyne-Rauzy O, Mittelman M, Muus P, Nimer SD, Hellström-Lindberg E, Powell BL, Guerci-Bresler A, Sekeres MA, Deeg HJ, Del Cañizo C, Greenberg PL, Shammo JM, Skikne B, Yu X, List AF. Fenaux P, et al. Among authors: shammo jm. J Hematol Oncol. 2017 Jun 26;10(1):131. doi: 10.1186/s13045-017-0491-2. J Hematol Oncol. 2017. PMID: 28651604 Free PMC article. Clinical Trial.
Idiopathic hemophagocytic syndrome with a fulminant clinical course.
Khandelwal A, Shah NB, Eichenseer P, Welker M, Miller I, Nangia J, Farhat M, Gimelfarb A, Kassar M, Batus M, Gezer S, Shammo J, Gregory S, Fung H, Venugopal P. Khandelwal A, et al. Clin Adv Hematol Oncol. 2008 Aug;6(8):587-90. Clin Adv Hematol Oncol. 2008. PMID: 18820601 Review. No abstract available.
39 results